| scholarly article | Q13442814 |
| P50 | author | Joseli Oliveira-Ferreira | Q47664416 |
| Tuan M Tran | Q50285663 | ||
| Josué da Costa Lima-Junior | Q56555271 | ||
| Salvatore Giovanni De-Simone | Q58860389 | ||
| Rodrigo Nunes Rodrigues-da-Silva | Q59690115 | ||
| Alberto Moreno | Q68159699 | ||
| P2093 | author name string | J. W. Barnwell | |
| J. Jiang | |||
| F. Santos | |||
| D. M. Banic | |||
| M. R. Galinski | |||
| R. Y. Ribeiro | |||
| V. S E. Meyer | |||
| P2860 | cites work | Comparative genomics of the neglected human malaria parasite Plasmodium vivax | Q22122202 |
| A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum | Q24814432 | ||
| Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region | Q28345224 | ||
| Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay | Q28394065 | ||
| The neglected burden of Plasmodium vivax malaria | Q29618450 | ||
| Vivax malaria: neglected and not benign | Q29619167 | ||
| Plasmodium vivax merozoite surface proteins-3beta and-3gamma share structural similarities with P. vivax merozoite surface protein-3alpha and define a new gene family | Q30671058 | ||
| Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain | Q30738627 | ||
| The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications | Q30838479 | ||
| Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia. | Q31154588 | ||
| Age dependent characteristics of protection v. susceptibility to Plasmodium falciparum | Q32048591 | ||
| Allelic dimorphism in the merozoite surface protein-3alpha in Korean isolates of Plasmodium vivax. | Q33210747 | ||
| Neglect of Plasmodium vivax malaria | Q33302477 | ||
| Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea | Q33344896 | ||
| Vivax malaria: a major cause of morbidity in early infancy | Q33384482 | ||
| How benign is benign tertian malaria? | Q33384880 | ||
| Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research | Q33393949 | ||
| Antibody epitope mapping using SPOT peptide arrays | Q33431995 | ||
| New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance | Q33477285 | ||
| Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon. | Q33817378 | ||
| Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen | Q34194609 | ||
| Mapping the global extent of malaria in 2005. | Q35034339 | ||
| The Plasmodium vivax genome sequencing project | Q35134468 | ||
| Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria | Q35546112 | ||
| Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals | Q35606249 | ||
| Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria | Q36353279 | ||
| Molecular basis for mutation in a surface protein expressed by malaria parasites | Q36439623 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites | Q36719890 | ||
| Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection | Q36751523 | ||
| Plasmodium vivax: who cares? | Q37018632 | ||
| Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species | Q37506803 | ||
| The persistent problem of malaria: addressing the fundamental causes of a global killer | Q39493379 | ||
| Genetic structures of geographically distinct Plasmodium vivax populations assessed by PCR/RFLP analysis of the merozoite surface protein 3beta gene | Q39614042 | ||
| Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status | Q40162910 | ||
| Plasmodium vivax infection: not so benign | Q40384624 | ||
| Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design | Q40491236 | ||
| Developments with anti-malarial vaccines. | Q40715913 | ||
| Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages | Q41835030 | ||
| STUDIES IN THE ACQUISITION OF IMMUNITY OF PLASMODIUM FALCIPARUM INFECTIONS IN AFRICA. | Q41944135 | ||
| Peptides as antigens. Importance of orientation | Q42026698 | ||
| A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. | Q42581710 | ||
| Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil | Q43498253 | ||
| Identification of a cryptic intron in the Plasmodium vivax Duffy binding protein gene | Q43527873 | ||
| Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys | Q44676194 | ||
| Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions | Q45063620 | ||
| Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. | Q46339260 | ||
| Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil | Q47842676 | ||
| A reticulocyte-binding protein complex of plasmodium vivax merozoites | Q47860897 | ||
| Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans | Q47911727 | ||
| Genetic structure of Plasmodium vivax isolates from two malaria endemic areas in Afghanistan | Q47912736 | ||
| Acquired immune response to defined Plasmodium vivax antigens in individuals residing in northern India | Q47923539 | ||
| Protection of rhesus monkeys against Plasmodium knowlesi infection with merozoite vaccine. | Q47924252 | ||
| Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein. | Q47930414 | ||
| Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development | Q47985901 | ||
| Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. | Q48003700 | ||
| Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax | Q48009489 | ||
| Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon. | Q48010530 | ||
| Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3alpha from the malaria parasite Plasmodium vivax in Thailand | Q48012612 | ||
| Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes | Q48013154 | ||
| Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. | Q48013929 | ||
| Polymorphism in the Plasmodium vivax msp 3: gene in field samples from Tierralta, Colombia. | Q54515621 | ||
| Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites | Q56379655 | ||
| Extensive polymorphism in the plasmodium vivax merozoite surface coat protein MSP-3alpha is limited to specific domains | Q56447214 | ||
| Malaria vaccines | Q59394149 | ||
| A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies | Q71757099 | ||
| SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes | Q71873230 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium vivax | Q311376 |
| antibody | Q79460 | ||
| malaria | Q12156 | ||
| P304 | page(s) | 1801-1811 | |
| P577 | publication date | 2011-01-06 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | |
| B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | |||
| P478 | volume | 29 |
| Q35877857 | A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions |
| Q37685993 | A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection |
| Q34606478 | Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3. |
| Q64110597 | Effect of low complexity regions within the PvMSP3α block II on the tertiary structure of the protein and implications to immune escape mechanisms |
| Q57285883 | Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3 |
| Q34078790 | Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon. |
| Q28477326 | Identification of Plasmodium vivax Proteins with Potential Role in Invasion Using Sequence Redundancy Reduction and Profile Hidden Markov Models |
| Q34234390 | Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis |
| Q35898819 | In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9 |
| Q34287358 | Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. |
| Q63045331 | Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog |
| Q97069798 | Insights into the molecular diversity of Plasmodium vivax merozoite surface protein-3γ (pvmsp3γ), a polymorphic member in the msp3 multi-gene family |
| Q38728598 | Insights into the naturally acquired immune response to Plasmodium vivax malaria |
| Q63634588 | Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia |
| Q26767472 | Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection |
| Q33899358 | Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC. |
| Q26772878 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria |
| Q46926980 | Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians. |
| Q37308698 | Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children |
| Q37627098 | Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants. |
| Q34744820 | Plasmodium vivax Merozoite Surface Protein-3 (PvMSP3): Expression of an 11 Member Multigene Family in Blood-Stage Parasites |
| Q39306087 | Rhoptry-associated protein (rap-1) genes in the sheep pathogen Babesia sp. Xinjiang: Multiple transcribed copies differing by 3' end repeated sequences |
| Q46758381 | Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area |
| Q28545082 | The Plasmodium vivax merozoite surface protein 3β sequence reveals contrasting parasite populations in southern and northwestern Thailand |
| Q40919228 | The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon |
| Q35524269 | The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites. |
| Q38062029 | Vaccines against Plasmodium vivax: a research challenge. |
| Q37638131 | What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates? |
Search more.